NCT04389034View on ClinicalTrials.gov

Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels

CompletedOBSERVATIONAL
Enrollment

113

Participants

Timeline

Start Date

April 22, 2020

Primary Completion Date

October 5, 2020

Study Completion Date

October 5, 2020

Conditions
Rhinitis, AllergicRespiratory Tract InfectionsAllergyAllergic AsthmaAllergic Conjunctivitis
Interventions
DRUG

Pollinex Quattro with tree- and grass pollen extracts and their mixtures

retrospective analysis of patient records of allergen-specific immunotherapy

Trial Locations (1)

Unknown

Outpatient Center Dr Stollewerk/Niebecker, Cologne

Sponsors
All Listed Sponsors
lead

Allergy Therapeutics

INDUSTRY